[1] Ledoux MS.Meige syndrome:what's in a name?[J].Parkinsonism & related disorders,2009,15(7):483~489. [2] Sun Y,Tsai P-J,Chu C-L,et al.Epidemiology of benign essential blepharospasm:A nationwide population-based retrospective study in Taiwan[J].PLoS One,2018,13(12):e0209558. [3] Butler AG,Duffey PO,Hawthorne MR,et al.An epidemiologic survey of dystonia within the entire population of northeast England over the past nine years[J].Advances in neurology,2004,94:95~99. [4] Le K-D,Nil Sen B,Dietrichs E.Prevalence of primary focal and segmental dystonia in Oslo[J].Neurology,2003,61(9):1294~1296. [5] Burke R E,Fahn S,Marsden CD,et al.Validity and reliability of a rating scale for the primary torsion dystonias[J].Neurology,1985,35(1):73~. [6] Sobstyl M,Brzuszkiewicz-KUMicka G,Zaxzyñski A,et al.Long-term clinical outcome of bilateral pallidal stimulation for intractable craniocervical dystonia (Meige syndrome).Report of 6 patients[J].Journal of the Neurological Sciences,2017,383:153~157. [7] Druzhinina O,Zhukova N,Shperling L.Non-motor conditions in patients with cervical dystonia[J].Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova,2020,120(10):7~13. [8] Albanese A,Bhatia K,Bressman SB,et al.Phenomenology and classification of dystonia:a consensus update[J].Movement disorders,2013,28(7):863~873. [9] Klingelhoefer L,Jost W,Odin P,et al.Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia:intercultural adaptation in the German language[J].Der Nervenarzt,2020,91:337~42. [10] KISIĉTepavĉEviĉ D,Svetel M,Pekmezoviĉ T,et al.Craniocervical Dystonia Questionnaire (CDQ-24):validation and cross-cultural adaptation in Serbian patients[J].Collegium antropologicum,2009,33(4):1185~1189. [11] Pandey S,Sharma S.Meige's syndrome:History,epidemiology,clinical features,pathogenesis and treatment[J].Journal of the neurological sciences,2017,372:162~170. [12] Kling Elhoefer L,Mar Tino D,Mar Tinez-Martin P,et al.Nonmotor symptoms and focal cervical dystonia:observations from 102 patients[J].Basal Ganglia,2014,4(3-4):117~120. [13] Fabbrini G,Berardellii,Moretti G,et al.Psychiatric disorders in adult‐onset focal dystonia:a case‐control study[J].Movement Disorders,2010,25(4):459~4565. [14] Leisman G,Melilloo R.The basal ganglia:motor and cognitive relationships in a clinical neurobehavioral context[J].Reviews in the Neurosciences,2013,24(1):9~25. [15] Ghilardi MF,Carbon M,Silvestri G,et al.Impaired sequence learning in carriers of the DYT1 dystonia mutation[J].Annals of neurology,2003,54(1):102~109. [16] Rinnerthaler M,Benecke C,Bartha L,et al.Facial recognition in primary focal dystonia[J].Movement Disorders:Official Journal of the Movement Disorder Society,2006,21(1):78~82.[17] Rafee S,Ndukwe I,O'riordan S,et al.Reliability of DNMSQuest as a Screening Tool for Mood Disorders in Cervical Dystonia[J].Movement Disorders Clinical Practice,2021,8(6):925~931. [18] Smait M,Kamphuis AS,Bartels AL,et al.Fatigue,sleep disturbances,and their influence on quality of life in cervical dystonia patients[J].Movement Disorders Clinical Practice,2017,4(4):517~523. [19] Page D,Butler A,Jahanshahi M.Quality of life in focal,segmental,and generalized dystonia[J].Movement disorders:official journal of the Movement Disorder Society,2007,22(3):341~347. [20] Pekmezovic T,Svetel M,Ivanovic N,et al.Quality of life in patients with focal dystonia[J].Clinical neurology and neurosurgery,2009,111(2):161~164. [21] Slawek J,Friedman A,Potulska A,et al.Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections[J].Functional neurology,2007,22(2):95. [22] Ben-Shlomo Y,Camfield L,Warner T.What are the determinants of quality of life in people with cervical dystonia?[J].Journal of Neurology,Neurosurgery & Psychiatry,2002,72(5):608~614. [23] Camfield L,Ben‐Shlomo Y,Warner TT,et al.Impact of cervical dystonia on quality of life[J].Movement disorders,2002,17(4):838~841. [24] MüLler J,Wissel J,Kemmler G,et al.Craniocervical dystonia questionnaire (CDQ-24):development and validation of a disease-specific quality of life instrument[J].Journal of Neurology,Neurosurgery & Psychiatry,2004,75(5):749~753. |